)
Lupin Limited received an approval from the US Food and Drug Administration (U SFDA) for generic PrandiMet, also known as Prandin used in type 2 diabetes.
Danish pharma company Novo Nordisk is the innovator of the drug that has been approved to lower blood glucose in adult patients.
The product is expected to have sales of $200-$300 million in the US. The drug could be limited competition for the company and can contribute around $ 50 million on sales, according to Sarabjit Kour Nangra of Angel Broking.
